Efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors as second-line treatment in postmenopausal patients with hormone receptor-positive, HER-2-negative metastatic breast cancer: a network meta-analysis

Leung, JH; Leung, HWC; Wang, SY; Huang, SS; Chan, ALF

Huang, SS (corresponding author), Ditmanson Med Fdn, Dept Obstet & Gynecol, Chiayi Christian Hosp, 539 Zhongxiao Rd, Chiayi 60002, Taiwan.; Chan, ALF (corresponding author), China Med Univ, An Nan Hosp, Dept Pharm, 66,Sec 2,Changhe Rd, Tainan, Taiwan.

EXPERT OPINION ON DRUG SAFETY, 2021; 20 (8): 949

Abstract

Background We compared the efficacy and safety of combinations of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and PI3K/AKT/mTOR inhibitors as seco......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索